- Home
- CZFS vs ANNX Comparison
CZFS vs ANNX Comparison
Compare CZFS & ANNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CZFS
- ANNX
- Stock Information
- Founded
- CZFS 1984
- ANNX 2011
- Country
- CZFS United States
- ANNX United States
- Employees
- CZFS N/A
- ANNX N/A
- Industry
- CZFS Major Banks
- ANNX Biotechnology: Pharmaceutical Preparations
- Sector
- CZFS Finance
- ANNX Health Care
- Exchange
- CZFS Nasdaq
- ANNX Nasdaq
- Market Cap
- CZFS 275.0M
- ANNX 253.8M
- IPO Year
- CZFS N/A
- ANNX 2020
- Fundamental
- Price
- CZFS $64.65
- ANNX $2.42
- Analyst Decision
- CZFS
- ANNX Strong Buy
- Analyst Count
- CZFS 0
- ANNX 5
- Target Price
- CZFS N/A
- ANNX $13.00
- AVG Volume (30 Days)
- CZFS 8.4K
- ANNX 1.8M
- Earning Date
- CZFS 10-29-2025
- ANNX 11-13-2025
- Dividend Yield
- CZFS 3.06%
- ANNX N/A
- EPS Growth
- CZFS 15.37
- ANNX N/A
- EPS
- CZFS 6.58
- ANNX N/A
- Revenue
- CZFS $104,184,000.00
- ANNX N/A
- Revenue This Year
- CZFS N/A
- ANNX N/A
- Revenue Next Year
- CZFS $5.45
- ANNX N/A
- P/E Ratio
- CZFS $9.82
- ANNX N/A
- Revenue Growth
- CZFS 6.11
- ANNX N/A
- 52 Week Low
- CZFS $49.99
- ANNX $1.29
- 52 Week High
- CZFS $75.40
- ANNX $7.85
- Technical
- Relative Strength Index (RSI)
- CZFS 65.66
- ANNX 56.00
- Support Level
- CZFS $61.00
- ANNX $2.03
- Resistance Level
- CZFS $63.50
- ANNX $2.70
- Average True Range (ATR)
- CZFS 1.56
- ANNX 0.15
- MACD
- CZFS 0.40
- ANNX 0.05
- Stochastic Oscillator
- CZFS 89.21
- ANNX 58.38
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.
About ANNX Annexon Inc.
Annexon Inc is a clinical-stage biopharmaceutical company developing a pipeline of novel therapies for patients with classical complement-mediated disorders of the body, brain, and eye. Its pipeline is based on its platform technology addressing well-researched classical complement-mediated autoimmune and neurodegenerative disease processes, both of which are triggered by aberrant activation of C1q. Its pipeline of product candidates is designed to block the activity of C1q and the entire classical complement pathway in a broad set of complement-mediated diseases. Its product candidates are ANX005, for autoimmune & neurodegenerative disorders; ANX007, for neurodegenerative ophthalmic disorders; ANX1502 for Oral small molecule; and ANX009, for systemic autoimmune diseases.